Skip to main content
logo
Ginkgo Bioworks Holdings, Inc. (DNA)
NYSE: DNA · Real-Time Price · USD
6.89
+0.07 (1.03%)
Apr 8, 2026, 1:31 PM EDT - Market open

Ginkgo Bioworks Holdings Revenue

In the year 2025, Ginkgo Bioworks Holdings had annual revenue of $170.16M, down -25.06%. Ginkgo Bioworks Holdings had revenue of $33.40M in the quarter ending December 31, 2025, a decrease of -23.84%.

Revenue (ttm)
$170.16M
Revenue Growth
-25.06%
P/S Ratio
2.35
Revenue / Employee
$350,835
Employees
485
Market Cap
401.05M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025170.16M-56.89M-25.06%
Dec 31, 2024227.04M-24.41M-9.71%
Dec 31, 2023251.46M-226.25M-47.36%
Dec 31, 2022477.71M163.87M52.21%
Dec 31, 2021313.84M237.18M309.40%
Dec 31, 202076.66M22.47M41.48%
Dec 31, 201954.18M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Vanda Pharmaceuticals216.11M
Century Therapeutics109.16M
Sutro Biopharma102.48M
Enanta Pharmaceuticals66.98M
XOMA Royalty52.15M
Lineage Cell Therapeutics14.56M
Armata Pharmaceuticals4.90M
Revenue Rankings

DNA News

More News